Experts from various countries join IIRSI 2025 ophthalmology convention in Chennai
The convention was launched by Anil Kumar Bachoo, Minister of Health & Wellness, Government of Mauritius, Palanivel Thiaga Rajan, Minister for Information Technology and digital Services, Government of Tamil Nadu, and Arthi Ganesh, Pro-Chancellor, Vels University.
Led by Satanshu Mathur, President, IIRSI, alongside Amar Agarwal, Secretary General, IIRSI, and Mahipal S. Sachdev, Chairman Scientific Committee-IIRSI, the convention attracted over 1,000 ophthalmologists, surgeons, researchers, and experts from around the world. The event featured foreign faculty lectures, live surgery, hands-on wet lab focussing on cataract, refractive and intraocular implantation.
At the inauguration, Mr. Bachoo highlighted Mauritius' commitment to free and universal eye care, its public health system, international collaborations, and ongoing efforts to build local ophthalmic capacity. He expressed gratitude to Indian medical institutions, especially those in Chennai, for their important role in treating complex cases and supporting Mauritius through training and specialised care.
Stephen McLeod, CEO of the American Academy of Ophthalmology, received a gold medal in recognition of his contributions to the field of ophthalmology. Several other individuals were also honored with awards. Ophthalmic experts Gaurav Luthra, Mohan Rajan, Rohit Om Prakash, Ragini Parekh were present.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
an hour ago
- Hans India
Pharma sector set for 11% YoY growth in Q1FY26 driven by global momentum: Report
Pharmaceutical companies in India are projected to deliver an 11% year-on-year (YoY) growth in both sales and EBITDA for the first quarter of FY26, according to a recent report by Kotak Institutional Equities. The growth is expected to be driven by sustained momentum across key international markets, despite slightly muted domestic demand in April and March. The hospital segment is also expected to shine with a robust 17% YoY increase in sales and EBITDA, attributed to increased patient footfalls, capacity expansions through new bed additions, and a modest improvement in Average Revenue Per Occupied Bed (ARPOB). Diagnostics players are forecast to see a 14% growth in sales, fueled by higher volumes, an improved service mix, and mergers and acquisitions activity. The Indian pharmaceutical market was valued at USD 50 billion in FY24, with domestic consumption contributing USD 23.5 billion and exports accounting for USD 26.5 billion. India continues to hold its place as the world's third-largest pharmaceutical producer by volume and 14th by value. The industry's portfolio spans generic and bulk drugs, OTC products, vaccines, biosimilars, and biologics. As per the National Accounts Statistics 2024, published by the Ministry of Statistics and Programme Implementation, the pharmaceutical sector's total output stood at ₹4.56 lakh crore for FY23 at constant prices, with ₹1.75 lakh crore as value added. With over 9.25 lakh people employed in the sector during FY23, the Indian government has been actively promoting pharmaceutical innovation. The Department of Pharmaceuticals has set up seven National Institutes of Pharmaceutical Education and Research (NIPERs) to foster advanced research and academic excellence. To accelerate innovation, the department has also rolled out the National Policy on R&D and Innovation in the Pharma-MedTech Sector, aimed at nurturing an entrepreneurial ecosystem and positioning India as a global leader in drug discovery and medical device development.
India Today
2 hours ago
- India Today
Vaccine hesitancy - India hesitancy: Two sides of the same dangerous coin
Vaccine hesitancy has a long history. Initially, vaccines were opposed on religious grounds, viewed as interference with divine will. Later, in liberal societies, they were resisted as infringements on personal freedom, especially when made modern times, the anti-vaccine movement gained steam from 1998 through a widely publicised study by Dr. Andrew Wakefield that falsely linked the MMR (Measles, Mumps and Rubella) vaccine to autism. Wakefield overlooked the crucial fact that autism often manifests around the same age at which the MMR vaccine is administered. Driven by the distress and assumptions of some parents who misread the timing of autism's onset as being triggered by the vaccine, Wakefield arrived at a deeply flawed conclusion. The study was later debunked and retracted, and Wakefield was discredited; however, the damage was lasting, fuelling vaccine suspicion, lowering immunisation rates, and contributing to outbreaks of preventable diseases, such as recent decades, vaccine resistance was further inflamed by conspiracy theories that framed vaccines as mere tools of profiteering corporations. During COVID, these historical strands of vaccine hesitancy - religious conservatism, libertarianism, and conspiracism - merged into a potent blend of distrust, politicisation, and misinformation, stoking a global wave of vaccine resistance that led to preventable illness and death across a similar blend of scientific distortion and political opportunism is evident in Karnataka's Chief Minister Siddaramaiah's recent tweets. Without offering any credible evidence, he hinted at a connection between the COVID-19 vaccines and a rise in heart attacks. His language - posing questions rather than making claims outright - mirrors a now-familiar strategy: sow doubt while evading responsibility. Like Wakefield, Siddaramaiah appears driven not by science, but by a confluence of ideology, misperception, and political is both striking and encouraging is that, this time, several prominent Indian industrialists have pushed back decisively against such misinformation. In a landscape where business leaders often tread cautiously amid political currents, their clarity is commendable. Foremost among them is Biocon's Kiran Mazumdar-Shaw, a rare business voice known for calling a spade a spade. She has long advocated for constructive criticism in India's industry-government interface, even echoing Rahul Bajaj's concerns that government criticism is often mislabelled as 'anti-national.' Despite her history of critiquing the regulatory process on occasions, she came out strongly in defense of India's vaccine oversight. Countering Siddaramaiah's charge of hasty approval and distribution, she tweeted:'COVID-19 vaccines developed in India were approved under the Emergency Use Authorisation framework, following rigorous protocols aligned with global standards for safety and efficacy. To suggest that these vaccines were 'hastily' approved is factually incorrect and contributes to public misinformation.'Kiran Mazumdar-Shaw articulated her response with precision, crafting it to be nearly unassailable and preempting any credible counterattack. So did Pankaj Bhai Patel, Dilip Shanghvi, Satish Reddy, and Sudarshan Jain. AIIMS and other leading institutions also convincingly defended the safety and efficacy of the vaccines, citing large-scale clinical trials and real-world data collected over millions of doses. The broader scientific community has reinforced this by pointing out that India's vaccines have not only protected its own people but were also supplied to over 70 countries, helping bridge global vaccine what makes this moment more troubling is that Siddaramaiah's anti-science insinuations are not isolated. Internationally, figures like Robert F. Kennedy Jr., US Secretary of Health and Human Sevices, continue to push vaccine skepticism - not as scientists, but as political actors. RFK Jr.'s crusade is rooted in libertarian distrust of federal institutions and often veers into conspiracy theory. More insidiously, Siddaramaiah's comments appear not only to undermine vaccines, but to subtly discredit the Indian scientific establishment, turning a global public health issue into a domestic political weapon. His sludge is thus not just anti-science - it edges toward being the establishment and Modi are near-synonymous today, attacking Indian institutions often doubles as an attack on Modi. Modi's opponents in India ask: why cut Modi slack when he's been ruthlessly below the belt with us? India is navigating a complex and competitive world where credibility, not partisanship, determines influence. Defending our institutions in this moment is not about giving anyone political cover - it's about protecting India's long-term standing and scientific supplies 60% of the world's vaccines and has done so reliably, safely, and at scale. At a time when the country is positioning itself as a trusted health partner to the world, amid shifting geopolitical and geo-commercial landscapes, ill-considered, uninformed criticism from within can do more damage than we realise. This is not the time to erode trust in one of India's most respected global contributions. It is time to defend must always be open to scrutiny, and governments must be held accountable. But there is a difference between honest inquiry and opportunistic delegitimisation. The former strengthens democracy and public health; the latter corrodes both. At a time when India is under external pressure and internal strain, spreading unsubstantiated fears erodes public trust and weakens our shared an age where trust is as critical as innovation, we must not only defend our science - we must stand behind those who uphold it, at home and on the world stage.(Pavan Choudary is the Chairman of the Medical Technology Association of India (MTaI) and a Public Intellectual)- Ends(Views expressed in this opinion piece are those of the author)Must Watch
Economic Times
4 hours ago
- Economic Times
Who's a 'real' doctor? How Chess grandmaster Vidit Gujrathi vs The Liver Doc's viral war of words began... over a selfie
Agencies Who's a Real Doctor? India's Heated Debate Begins with a Family Selfie On July 1, 2025, Indian chess grandmaster Vidit Gujrathi posted a heartfelt tribute to his family on X (formerly Twitter) in honor of National Doctors' Day. The message, accompanied by a selfie featuring his wife, parents, and sister, expressed his admiration and appreciation for the medical professionals in his family. While the post was intended as a gesture of gratitude, it quickly became the center of a major online controversy about who is truly eligible to be called a 'doctor' in India. Curious followers soon began asking about the specific fields of expertise held by his family members. In response, Gujrathi explained that his father is an Ayurvedic migraine specialist, his wife holds an MD in homeopathy, his mother works in cosmetology, and his sister is a physiotherapist. Initially, the post was met with warmth. However, within 24 hours, the tone shifted drastically. On July 2, Dr. Cyriac Abby Philips, a hepatologist better known on social media as The Liver Doc, responded sharply to Gujrathi's post. In a blunt statement, Dr. Philips asserted that the individuals mentioned in the tribute should not be classified as doctors. This response sparked a flurry of reactions, quickly dividing social media into supporters and critics. — theliverdr (@theliverdr) The Liver Doc, known for his firm stance against unscientific practices in healthcare, argued that Ayurveda, homeopathy, cosmetology, and physiotherapy do not fall under the scope of conventional clinical medicine. Although he acknowledged that physiotherapy is a legitimate branch of healthcare that supports recovery and rehabilitation, he firmly stated that the other disciplines lack clinical validation. His especially severe comments about homeopathy, which he controversially associated with historical pseudoscientific movements, inflamed the situation Gujrathi did not remain silent. He defended his family, stating that they were all formally trained, qualified, and certified practitioners in their respective fields. He emphasized their commitment to serving others and the impact they have made over the years, even if they weren't working in the limelight. Though he later deleted his original post, Gujrathi posted screenshots of his conversation with The Liver Doc, accusing him of seeking attention by publicly attacking others instead of celebrating their contributions. — viditchess (@viditchess) In his follow-up, Gujrathi expressed that his intention was simply to honour his loved ones. He admitted he initially chose to stay quiet but felt compelled to speak out after what he described as mockery and dismissal of his family's work. He stressed that critics on social media cannot determine who deserves to be called a doctor, especially when individuals in his family have devoted their lives to helping people through alternative systems of medicine. — theliverdr (@theliverdr) — viditchess (@viditchess) According to a report by India Today , the term 'doctor' in India is not restricted to those with MBBS or MD degrees in modern allopathic medicine. Under the jurisdiction of the Ministry of AYUSH, professionals holding degrees like BAMS (Bachelor of Ayurvedic Medicine and Surgery) and BHMS (Bachelor of Homeopathic Medicine and Surgery) are legally recognized as doctors. These individuals are allowed to use the prefix "Dr." before their names and are registered under statutory bodies such as the Central Council of Indian Medicine (CCIM) and the Central Council of Homeopathy (CCH).However, these councils are separate from the National Medical Commission (NMC), which governs allopathic medical practitioners. While AYUSH doctors can legally practice within their respective disciplines, they are not authorized to prescribe allopathic medication or present themselves as clinical physicians. This legal distinction often blurs in everyday practice, particularly in rural and semi-urban areas where access to conventional healthcare is controversy highlights a persistent tension in India's healthcare landscape. While traditional systems like Ayurveda and homeopathy have deep cultural roots and legal recognition, they continue to be contested by many from the modern medical though integral to patient recovery, are not granted the title of 'doctor' under standard clinical definitions. Cosmetologists, on the other hand, may or may not be doctors depending on their educational background—if they hold an MBBS or equivalent degree in dermatology or aesthetic medicine, they may the end, what started as a tribute evolved into a conversation about professional legitimacy, public perception, and the evolving definition of a doctor in modern India. As the debate unfolds, one thing is certain: the divide between traditional and modern medicine continues to challenge India's healthcare identity.
